Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis.
Antonios BertsiasIrini D FlouriArgyro RepaNestor AvgoustidisEleni KalogiannakiSofia PitsigavdakiGeorge K BertsiasProdromos SidiropoulosPublished in: RMD open (2024)
D2T patients represent a heterogeneous group in terms of long-term disease course. Mental-health/pain-related illnesses as well as metabolic diseases contribute to long-term adverse outcomes and should be targeted in order to optimise the prognosis of this subset of rheumatoid arthritis.
Keyphrases
- rheumatoid arthritis
- disease activity
- systemic lupus erythematosus
- mental health
- ankylosing spondylitis
- rheumatoid arthritis patients
- end stage renal disease
- ejection fraction
- juvenile idiopathic arthritis
- chronic pain
- newly diagnosed
- chronic kidney disease
- prognostic factors
- pain management
- cancer therapy
- idiopathic pulmonary fibrosis
- patient reported